Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Mallinckrodt
Johnson and Johnson
Merck
McKinsey

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Zidebactam

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Zidebactam: Sponsors, patents, clinical trial progress

Zidebactam is an investigational drug.

There have been 4 clinical trials for Zidebactam. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.

The most common disease conditions in clinical trials are Renal Insufficiency and [disabled in preview]. The leading clinical trial sponsors are Wockhardt, Quintiles, Inc., and Clinartis.

There are seven US patents protecting this investigational drug and sixty-five international patents.

Recent Clinical Trials for Zidebactam
TitleSponsorPhase
Plasma and Intrapulmonary Concentrations Study of WCK 5222WockhardtPhase 1
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal ImpairmentClinartisPhase 1
To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal ImpairmentWockhardtPhase 1

See all Zidebactam clinical trials

Clinical Trial Summary for Zidebactam

Top disease conditions for Zidebactam
Top clinical trial sponsors for Zidebactam

See all Zidebactam clinical trials

US Patents for Zidebactam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Zidebactam   Start Trial Pharmaceutical compositions comprising antibacterial agents WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN)   Start Trial
Zidebactam   Start Trial Nitrogen containing compounds Wockhardt Ltd. (Bandra-Kurla Complex, Bandra East, Mumbai, IN)   Start Trial
Zidebactam   Start Trial Compositions and methods for treating bacterial infections WOCKHARDT LIMITED (Chikalthana, IN)   Start Trial
Zidebactam   Start Trial Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Zidebactam

Drugname Country Document Number Estimated Expiration Related US Patent
Zidebactam Australia 2015208830 1989-12-31   Start Trial
Zidebactam Canada 2954553 1989-12-31   Start Trial
Zidebactam European Patent Office 3217979 1989-12-31   Start Trial
Zidebactam India 193MU2014 1989-12-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
McKinsey
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.